Breaking News Instant updates and real-time market news.

BDX

Becton Dickinson

$191.56

-2.44 (-1.26%)

, BCR

Bought by BDX

$317.37

-1.19 (-0.37%)

05:20
09/22/17
09/22
05:20
09/22/17
05:20

Becton Dickinson initiated with an Outperform at Wells Fargo

Wells Fargo analyst Larry Biegelsen started Becton Dickinson (BDX) with an Outperform rating and $225 price target. The analyst sees potential upside to C.R. Bard (BCR) acquisition accretion and believes any potential impact from the hurricanes in Q4 will be short-term.

BDX

Becton Dickinson

$191.56

-2.44 (-1.26%)

BCR

Bought by BDX

$317.37

-1.19 (-0.37%)

BDX Becton Dickinson
$191.56

-2.44 (-1.26%)

05/23/17
MSCO
05/23/17
NO CHANGE
MSCO
Medtech Technology sector upgraded to Attractive from In-Line at Morgan Stanley
Morgan Stanley upgraded the Medtech Technology sector to Attractive saying structural fundamentals have improved and recent acceleration will likely continue, driving further multiple expansion.
06/30/17
RAJA
06/30/17
UPGRADE
Target $226
RAJA
Strong Buy
Becton Dickinson upgraded to Strong Buy from Outperform at Raymond James
Raymond James analyst Lawrence Keusch upgraded Becton Dickinson to Strong Buy from Outperform and increased its price target to $226 from $210 and believes it should be a core holding based an an above average outlook for 5-6% organic growth and mid-teens earnings increases with further potential upside. The analyst views the C.R. Bard acquisition as a sold strategic fit with an accelerating growth profile given its deep R&D pipeline and sizeable addressable market opportunities. Post close, he sees strong free cash flow generation of $10B from 2018-2020, allowing the company to rapidly deleverage to 3x in 2020 from 4.7x.
06/30/17
06/30/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Cabot Oil & Gas (COG) upgraded to Buy from Neutral at BofA/Merrill with analyst Doug Leggate saying Cabot 's gross Marcellus takeaway capacity will increase to 3.7 bcf/d from 2bcf/d by end of 2018 and positioned to increase free cash flow to $2B from $872M per year for 25 years. 2. Becton Dickinson (BDX) upgraded to Strong Buy from Outperform at Raymond James with analyst Lawrence Keusch saying he believes it should be a core holding based an an above average outlook for 5%-6% organic growth and mid-teens earnings increases with further potential upside. 3. Walgreens Boots Alliance (WBA) upgraded to Buy from Hold at Needham. 4. ManTech (MANT) upgraded to Buy from Hold at Loop Capital with analyst Joseph Vafi saying he sees "company-specific and secular catalysts" driving improving fundamentals and upward revisions to consensus estimates. 5. D.R. Horton (DHI) upgraded to Outperform from Market Perform at Raymond James with the firm saying it is uniquely positioned to capitalize on an unexpectedly tight and historically low existing home inventories, while new home demand remains broadly resilient despite rising prices. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/12/17
COWN
09/12/17
NO CHANGE
COWN
Cowen says cervical cancer recommendations a risk for Hologic, Becton Dickinson
Cowen analyst Doug Schenkel noted that the US Preventive Services Task Force recently released a draft recommendation on cervical cancer screening, which no longer recommends cotesting with both an HPV assay and cytology, which would be a negative for Hologic (HOLX) and Becton Dickinson (BDX) if the draft is implemented. If the draft is implemented, it is likely a positive for Roche (RHHBY), the only vendor with a primary screening HPV assay that is FDA approved, added Schenkel. However, the final recommendation statement can be materially different from the draft, he said.
BCR Bought by BDX
$317.37

-1.19 (-0.37%)

04/24/17
MSCO
04/24/17
DOWNGRADE
MSCO
Equal Weight
C.R. Bard downgraded to Equal Weight from Overweight at Morgan Stanley
Morgan Stanley analyst David Lewis downgraded C.R. Baird (BCR) to Equal Weight following the acquisition announcement by Becton Dickinson (BDX) saying a higher bid is unlikely.
04/25/17
BMOC
04/25/17
DOWNGRADE
BMOC
Market Perform
C.R. Bard downgraded to Market Perform from Outperform at BMO Capital
C.R. Bard (BCR) is being acquired by Beckton Dickinson for (BDX) for $317 per share.
04/25/17
RAJA
04/25/17
DOWNGRADE
RAJA
Market Perform
C.R. Bard downgraded to Market Perform from Strong Buy at Raymond James
C.R. Bard (BCR) is being acquired by Beckton Dickinson for (BDX) for $317 per share.
04/25/17
LEER
04/25/17
NO CHANGE
Target $317
LEER
Market Perform
C.R. Bard price target raised to $317 from $246 at Leerink
Leerink analyst Richard Newitter raised his price target for C.R. Bard (BCR) to $317 from $246 following the announced acquisition price from Becton Dickinson (BDX). The analyst reiterates a Market Perform rating as he believes the deal price fully values C.R. Bard and sees limited risk of a competitive bid or barriers from the FTC.

TODAY'S FREE FLY STORIES

CPB

Campbell Soup

$45.10

-0.985 (-2.14%)

, LNCE

Snyder's-Lance

$50.00

0.05 (0.10%)

11:55
02/21/18
02/21
11:55
02/21/18
11:55
Hot Stocks
Campbell expects $170M in cost synergies from Snyder's-Lance deal by FY22 »

CFO Anthony DiSilvestro…

CPB

Campbell Soup

$45.10

-0.985 (-2.14%)

LNCE

Snyder's-Lance

$50.00

0.05 (0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 23

    Apr

  • 30

    May

HBAN

Huntington Bancshares

$15.90

0.07 (0.44%)

11:50
02/21/18
02/21
11:50
02/21/18
11:50
Options
Call buyers in Huntington Bancshares »

Call buyers in Huntington…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

11:50
02/21/18
02/21
11:50
02/21/18
11:50
General news
Treasury $15 B 2-year FRN reopening was weak »

Treasury $15 B 2-year FRN…

C

Citi

$77.50

1.0399 (1.36%)

11:47
02/21/18
02/21
11:47
02/21/18
11:47
Periodicals
Citi creates new position to supervise EMEA commodities banking, FT says »

According to the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 06

    Mar

  • 07

    Mar

  • 30

    May

XLI

Industrial Select Sector SPDR

$77.42

0.905 (1.18%)

, XLF

Financial Select Sector

$29.21

0.32 (1.11%)

11:43
02/21/18
02/21
11:43
02/21/18
11:43
Technical Analysis
Technical Take: S&P 500 hits session highs at midday »

At time of writing the…

XLI

Industrial Select Sector SPDR

$77.42

0.905 (1.18%)

XLF

Financial Select Sector

$29.21

0.32 (1.11%)

XLB

S&P Select Materials SPDR

$60.73

0.52 (0.86%)

XLK

Technology Select Sector SPDR

$67.79

0.55 (0.82%)

XLRE

Real Estate SPDR

$30.23

-0.145 (-0.48%)

XLP

Consumer Staples Sector SPDR

$54.16

-0.18 (-0.33%)

SPY

SPDR S&P 500 ETF Trust

$273.35

1.945 (0.72%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFE

Pfizer

$36.31

0.3 (0.83%)

, BIIB

Biogen

$287.45

-4.42 (-1.51%)

11:43
02/21/18
02/21
11:43
02/21/18
11:43
Periodicals
Breaking Periodicals news story on Pfizer, Biogen, Roche »

Pfizer loses IPR…

PFE

Pfizer

$36.31

0.3 (0.83%)

BIIB

Biogen

$287.45

-4.42 (-1.51%)

RHHBY

Roche

$29.77

-0.53 (-1.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 08

    Mar

  • 08

    Mar

  • 04

    Apr

  • 30

    May

SLCA

U.S. Silica

$26.56

-4.195 (-13.64%)

11:40
02/21/18
02/21
11:40
02/21/18
11:40
Options
Buy the dip call activity in Silica Holdings as shares tumble on earnings »

Buy the dip call activity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 30

    May

CPB

Campbell Soup

$45.44

-0.64 (-1.39%)

, LNCE

Snyder's-Lance

$50.00

0.05 (0.10%)

11:36
02/21/18
02/21
11:36
02/21/18
11:36
Hot Stocks
Campbell expects Snyder's-Lance deal to deliver 'significant' cost synergies »

Says Snyder's-Lance…

CPB

Campbell Soup

$45.44

-0.64 (-1.39%)

LNCE

Snyder's-Lance

$50.00

0.05 (0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 23

    Apr

  • 30

    May

11:36
02/21/18
02/21
11:36
02/21/18
11:36
General news
2-Yr FRN Note Auction Bid/Cover data reported »

2-Yr FRN Note Auction…

11:36
02/21/18
02/21
11:36
02/21/18
11:36
General news
2-Yr FRN Note Auction Total Amount data reported »

2-Yr FRN Note Auction…

PCRX

Pacira

$31.25

1.1 (3.65%)

11:36
02/21/18
02/21
11:36
02/21/18
11:36
Recommendations
Pacira analyst commentary  »

Pacira Q4 sales momentum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 06

    Apr

AIDIF

Air Canada

11:35
02/21/18
02/21
11:35
02/21/18
11:35
Conference/Events
Air Canada management to meet with RBC Capital »

Group Luncheon Meeting to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:30
02/21/18
02/21
11:30
02/21/18
11:30
Options
25K Alerian MLP Mar 9th 10.5 puts trade for 20c on ISE »

25K Alerian MLP Mar 9th…

CPB

Campbell Soup

$45.38

-0.7 (-1.52%)

11:30
02/21/18
02/21
11:30
02/21/18
11:30
Hot Stocks
Campbell Soup says goal is to become leading health and well-being food company »

President and CEO Denise…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 23

    Apr

  • 30

    May

PERY

Perry Ellis

$26.32

-0.52 (-1.94%)

11:28
02/21/18
02/21
11:28
02/21/18
11:28
Hot Stocks
Perry Ellis announces mens underwear, loungewear license in South Korea »

Earlier today, Perry…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBL

Noble Energy

$29.48

0.36 (1.24%)

11:27
02/21/18
02/21
11:27
02/21/18
11:27
Recommendations
Noble Energy analyst commentary  »

Noble Energy price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

DVN

Devon Energy

$32.86

-1.79 (-5.17%)

11:26
02/21/18
02/21
11:26
02/21/18
11:26
Hot Stocks
Devon Energy CEO confident that investor returns will increase in FY18 »

Devon Energy CEO David…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 28

    Feb

T

AT&T

$36.92

0.15 (0.41%)

, TWX

Time Warner

$95.26

0.19 (0.20%)

11:24
02/21/18
02/21
11:24
02/21/18
11:24
Conference/Events
FBN Securities media analyst to hold an analyst/industry conference call »

Media Analyst Research…

T

AT&T

$36.92

0.15 (0.41%)

TWX

Time Warner

$95.26

0.19 (0.20%)

DIS

Disney

$106.30

0.32 (0.30%)

FOX

21st Century Fox

$36.61

-0.43 (-1.16%)

SNI

Scripps Networks

$88.16

0.35 (0.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 26

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

  • 01

    Mar

  • 01

    Mar

  • 05

    Mar

  • 06

    Mar

  • 23

    Apr

DIS

Disney

$106.34

0.36 (0.34%)

11:23
02/21/18
02/21
11:23
02/21/18
11:23
Periodicals
Producer of new 'Frozen' musical accused of workplace harassment, WSJ says »

Tom Schumacher, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 26

    Feb

  • 01

    Mar

FB

Facebook

$176.01

-1.35 (-0.76%)

, TWTR

Twitter

$32.80

-0.04 (-0.12%)

11:22
02/21/18
02/21
11:22
02/21/18
11:22
Conference/Events
FBN Securities digital media analysts to hold a luncheon »

Digital Media Analysts…

FB

Facebook

$176.01

-1.35 (-0.76%)

TWTR

Twitter

$32.80

-0.04 (-0.12%)

GOOG

Alphabet

$1,102.46

7.66 (0.70%)

GOOGL

Alphabet Class A

$1,103.59

8.09 (0.74%)

AABA

Altaba

$74.59

1.08 (1.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 26

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

  • 07

    Mar

  • 18

    Mar

RF

Regions Financial

$19.77

0.37 (1.91%)

11:20
02/21/18
02/21
11:20
02/21/18
11:20
Options
Notable call buying in Regions Financial as shares move higher »

Notable call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

11:17
02/21/18
02/21
11:17
02/21/18
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

11:16
02/21/18
02/21
11:16
02/21/18
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:14
02/21/18
02/21
11:14
02/21/18
11:14
Conference/Events
RBC Capital healthcare IT analyst to hold a luncheon »

Healthcare IT Analyst…

GRMN

Garmin

$64.86

-0.35 (-0.54%)

, BMWYY

BMW

$35.62

-1.01 (-2.76%)

11:12
02/21/18
02/21
11:12
02/21/18
11:12
Hot Stocks
Garmin says still seeing lot of interest for infotainment for auto »

A company executive…

GRMN

Garmin

$64.86

-0.35 (-0.54%)

BMWYY

BMW

$35.62

-1.01 (-2.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 26

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.